Elena A. Prokupets
Director/Board Member at Acetylon Pharmaceuticals, Inc.
Profile
Elena A.
Prokupets has worked as a Managing Director at Metropolitan Opera Association, Inc. and as a Director at Acetylon Pharmaceuticals, Inc.
Elena A. Prokupets active positions
| Companies | Position | Start |
|---|---|---|
Metropolitan Opera Association, Inc.
 Metropolitan Opera Association, Inc. Movies/EntertainmentConsumer Services Metropolitan Opera Association, Inc. organizes and performs opera shows in its residence at the Lincoln Center of Performing Arts. The firm offers services in association with sponsors, such as Texaco. It produces radio, television and compact disk recordings of the performances and distributes them around the world. The company was founded in 1883 and is headquartered in New York, NY. | Corporate Officer/Principal | 2010-11-30 |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Metropolitan Opera Association, Inc.
Metropolitan Opera Association, Inc. Movies/EntertainmentConsumer Services Metropolitan Opera Association, Inc. organizes and performs opera shows in its residence at the Lincoln Center of Performing Arts. The firm offers services in association with sponsors, such as Texaco. It produces radio, television and compact disk recordings of the performances and distributes them around the world. The company was founded in 1883 and is headquartered in New York, NY. | Consumer Services |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Elena A. Prokupets